Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01119729
Other study ID # FKZ 01GI0205
Secondary ID
Status Completed
Phase N/A
First received May 7, 2010
Last updated May 7, 2010

Study information

Verified date May 2010
Source University Hospital, Essen
Contact n/a
Is FDA regulated No
Health authority Germany: Federal Ministry of Education and Reserach (BMBF) represented by the DLR Project Agency
Study type Observational

Clinical Trial Summary

Human immunodeficiency virus (HIV) infection has been associated with a variety of cardiovascular diseases. Even most industrialised countries exhibit a growing and aging population of HIV-infected patients in the majority treated with antiretroviral drugs, the investigators still do not know much about the impact of cardiovascular diseases in this group of patients. The present study is an ongoing trial that was conducted as a prospective and multicentre survey, being schemed to analyse the frequency and clinical course of cardiac disorders in HIV-infected patients.


Recruitment information / eligibility

Status Completed
Enrollment 803
Est. completion date
Est. primary completion date
Accepts healthy volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Age > 18 years

- Known HIV-infection

- Outpatients

- Written informed consent

Exclusion Criteria:

? Acute cardiovascular disease or unstable hemodynamic status in the three weeks before inclusion

• Pregnancy

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms

  • Cardiovascular Diseases
  • Detection of Frequency, Severity and Progression of Cardiovascular Diseases in Patients With HIV-infection.
  • Effect on Cardiovascular Risk and Life Quality by Age, Gender, Classic Cardiovascular Risk Factors,
  • HIV Infections
  • HIV-specific Cardiovascular Risk Factors, Cardiovascular Medication, Antiretroviral Medication

Locations

Country Name City State
Germany Department of Dermatology, University Hospital of Bochum Bochum NRW
Germany HIV Outpatient Department Dortmund NRW
Germany HIV Outpatient Department Duisburg NRW
Germany HIV Outpatients Department Duisburg NRW
Germany Department of Dermatology, University Hospital of Essen Essen NRW
Germany HIV Outpatient Department Essen NRW
Germany West German Heart Center Essen Essen NRW

Sponsors (2)

Lead Sponsor Collaborator
University Hospital, Essen Federal Ministry of Education and Reserach (BMBF)

Country where clinical trial is conducted

Germany, 

References & Publications (5)

Neumann T, Esser S, Potthoff A, Pankuweit S, Neumann A, Breuckmann F, Neuhaus K, Kondratieva J, Buck T, Müller-Tasch T, Wachter R, Prettin C, Gelbrich G, Herzog W, Pieske B, Rauchhaus M, Löffler M, Maisch B, Mügge A, Wasem J, Gerken G, Brockmeyer NH, Erbel R; HIV-HEART Study Investigative Group. Prevalence and natural history of heart failure in outpatient HIV-infected subjects: rationale and design of the HIV-HEART study. Eur J Med Res. 2007 Jun 27;12(6):243-8. — View Citation

Neumann T, Reinsch N, Neuhaus K, Brockmeyer N, Potthoff A, Esser S, Hower M, Neumann A, Mostardt S, Gelbrich G, Erbel R; für die HIV-HEART-Studie sowie die Kompetenznetze Herzinsuffizienz und HIV/AIDS. [BNP in HIV-infected patients]. Herz. 2009 Dec;34(8): — View Citation

Neumann T. [HIV, AIDS and the cardiovascular risk]. Internist (Berl). 2008 Apr;49(4):429-30, 432-5. doi: 10.1007/s00108-008-2049-4. Review. German. — View Citation

Reinsch N, Buhr C, Krings P, Kaelsch H, Kahlert P, Konorza T, Neumann T, Erbel R; Competence Network of Heart Failure. Effect of gender and highly active antiretroviral therapy on HIV-related pulmonary arterial hypertension: results of the HIV-HEART Study — View Citation

Reinsch N, Buhr C, Krings P, Kaelsch H, Neuhaus K, Wieneke H, Erbel R, Neumann T; German Heart Failure Network. Prevalence and risk factors of prolonged QTc interval in HIV-infected patients: results of the HIV-HEART study. HIV Clin Trials. 2009 Jul-Aug;1 — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Prevalence of cardiovascular diseases Prevalence of cardiovascular diseases including coronary artery disease, congestive heart failure, peripheral arterial disease, cerebrovascular events, and valvular diseases.
Secondary Prevalence of cardiovascular disorders Prevalence of cardiovascular disorders determined by electrocardiography, exercise testing, echocardiography, blood samples.